298 related articles for article (PubMed ID: 28986406)
1. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.
Beggs SAS; Jhund PS; Jackson CE; McMurray JJV; Gardner RS
Heart; 2018 Jan; 104(2):144-150. PubMed ID: 28986406
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
3. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Stavrakis S; Asad Z; Reynolds D
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.
Barakat AF; Saad M; Elgendy AY; Mentias A; Abuzaid A; Mahmoud AN; Elgendy IY
BMJ Open; 2017 Jun; 7(6):e016352. PubMed ID: 28637742
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials.
Romero J; Díaz JC; Grushko M; Quispe R; Briceno D; Avendano R; Golive A; Pina I; Natale A; Garcia MJ; Jorde UP; Di Biase L
Europace; 2018 Sep; 20(FI2):f211-f216. PubMed ID: 29161424
[TBL] [Abstract][Full Text] [Related]
7. Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.
Romero J; Chaudhary R; Garg J; Lupercio F; Shah N; Gupta R; Nazir T; Bozorgnia B; Natale A; Di Biase L
J Interv Card Electrophysiol; 2017 Sep; 49(3):263-270. PubMed ID: 28674918
[TBL] [Abstract][Full Text] [Related]
8. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
Desai AS; Fang JC; Maisel WH; Baughman KL
JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919
[TBL] [Abstract][Full Text] [Related]
9. Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Luni FK; Singh H; Khan AR; Malik SA; Khawaja O; Riaz H; Lee W; Kabour A; Richards M; Aasbo J
J Cardiovasc Electrophysiol; 2017 May; 28(5):538-543. PubMed ID: 28370885
[TBL] [Abstract][Full Text] [Related]
10. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
[TBL] [Abstract][Full Text] [Related]
11. Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy.
Cavalcanti R; Aboul-Hosn N; Morales G; Abdel-Latif A
Angiology; 2018 Apr; 69(4):297-302. PubMed ID: 28554215
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis.
Alba AC; Foroutan F; Duero Posada J; Battioni L; Schofield T; Alhussein M; Agoritsas T; Spencer FA; Guyatt G
Heart; 2018 Feb; 104(3):230-236. PubMed ID: 28780582
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.
Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V
Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
[TBL] [Abstract][Full Text] [Related]
15. Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy.
Pathak RK; Sanders P; Deo R
Eur Heart J; 2018 Aug; 39(31):2859-2866. PubMed ID: 30020440
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S
JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis.
Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ
Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177
[TBL] [Abstract][Full Text] [Related]
19. Should Primary Prevention ICDs Still Be Placed in Patients with Non-ischemic Cardiomyopathy? A Review of the Evidence.
Ganga HV; Maan A; Kevin Heist E
Curr Cardiol Rep; 2018 Mar; 20(5):31. PubMed ID: 29574588
[TBL] [Abstract][Full Text] [Related]
20. Current Device Therapies for Sudden Cardiac Death Prevention - the ICD, Subcutaneous ICD and Wearable ICD.
Chieng D; Paul V; Denman R
Heart Lung Circ; 2019 Jan; 28(1):65-75. PubMed ID: 30389367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]